no statement of use filed
on 03 Sep 2018
Last Applicant/ Owned by
840 Memorial Drive
Cambridge
MA
02139
Serial Number
87519680 filed on 07th Jul 2017
Registration Number
N/A
Correspondent Address
Christina M. Licursi, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocriRead More
Chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in scientific and medical research; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, and nutrients and nutritive products for use in the manufacture of beverages, food products and food supplements for human and non-human use; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, and muscle, bones, joints, and whole body movement; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussion, movement disorders, dystrophies, anemias, and orphan diseases; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for in vitro medical research and in vivo scientific research
pharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medicines, namely, proteins, biomolecules in the nature of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and amino acid metabolites for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medical foods, namely, food that is intended for the specific dietary management of a disease or condition; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; dietary and nutritional supplements
No 87519680
No Service/Collective Mark
No A119620010US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 04th Sep 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 03rd Sep 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| 30th Jan 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 05th Dec 2017 | PUBLISHED FOR OPPOSITION |
| 05th Dec 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Nov 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Oct 2017 | ASSIGNED TO LIE |
| 11th Oct 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 11th Oct 2017 | EXAMINER'S AMENDMENT ENTERED |
| 11th Oct 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
